Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Aurélie Hatton

2PUBLICATIONS

16CO-AUTHORS

Cross-sectional analysisPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Sep 11, 2023

Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription.

Elise Dreano, Pierre Régis Burgel, Aurelie Hatton

|Nov 11, 2021

Correlating genotype with phenotype using CFTR-mediated whole-cell Cl<sup>-</sup> currents in human nasal epithelial cells.

Sabrina Noel, Nathalie Servel, Aurélie Hatton

Pageof 1

Frequent Collaborators

2 joint publications

Alexandre Hinzpeter

2 joint publications

Isabelle Sermet-Gaudelus

1 joint publications

Sabrina Noel

1 joint publications

Nathalie Servel

1 joint publications

Anita Golec

1 joint publications

Mayuree Rodrat

1 joint publications

Demi R S Ng

1 joint publications

Hongyu Li

1 joint publications

Aleksander Edelman

1 joint publications

David N Sheppard

Frequent Collaborators

2 joint publications

Alexandre Hinzpeter

2 joint publications

Isabelle Sermet-Gaudelus

1 joint publications

Sabrina Noel

1 joint publications

Nathalie Servel

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on : Jul 04, 2018

See more related videos

Top Related Videos

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on : Jul 04, 2018

See more related videos